6.
Kerru N, Gummidi L, Maddila S, Gangu K, Jonnalagadda S
. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules. 2020; 25(8).
PMC: 7221918.
DOI: 10.3390/molecules25081909.
View
7.
Mavrova A, Denkova P, Tsenov Y, Anichina K, Vutchev D
. Synthesis and antitrichinellosis activity of some bis(benzimidazol-2-yl)amines. Bioorg Med Chem. 2007; 15(18):6291-7.
DOI: 10.1016/j.bmc.2007.06.017.
View
8.
Wesselinova D, Neykov M, Kaloyanov N, Toshkova R, Dimitrov G
. Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives. Eur J Med Chem. 2009; 44(6):2720-3.
DOI: 10.1016/j.ejmech.2009.01.036.
View
9.
Hosseinpour Moghadam N, Salehzadeh S, Tanzadehpanah H, Saidijam M, Karimi J, Khazalpour S
. In vitro cytotoxicity and DNA/HSA interaction study of triamterene using molecular modelling and multi-spectroscopic methods. J Biomol Struct Dyn. 2018; 37(9):2242-2253.
DOI: 10.1080/07391102.2018.1489305.
View
10.
Slater T, Sawyer B, STRAEULI U
. STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS. Biochim Biophys Acta. 1963; 77:383-93.
DOI: 10.1016/0006-3002(63)90513-4.
View
11.
Sheldrick G
. A short history of SHELX. Acta Crystallogr A. 2007; 64(Pt 1):112-22.
DOI: 10.1107/S0108767307043930.
View
12.
Macrae C, Sovago I, Cottrell S, Galek P, McCabe P, Pidcock E
. : from visualization to analysis, design and prediction. J Appl Crystallogr. 2020; 53(Pt 1):226-235.
PMC: 6998782.
DOI: 10.1107/S1600576719014092.
View
13.
Shalini , Kumar V
. Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?. Expert Opin Drug Discov. 2020; 16(4):335-363.
DOI: 10.1080/17460441.2021.1850686.
View
14.
Yang W, Ju J, Lee K, Shin I
. Akt isoform-specific inhibition of MDA-MB-231 cell proliferation. Cell Signal. 2010; 23(1):19-26.
DOI: 10.1016/j.cellsig.2010.07.016.
View
15.
Arjmand F, Parveen S, Afzal M, Shahid M
. Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial and topoisomerase I) and molecular docking of copper(II) benzimidazole complexes. J Photochem Photobiol B. 2012; 114:15-26.
DOI: 10.1016/j.jphotobiol.2012.05.003.
View
16.
Oh S, Ju J, Yang W, Lee K, Nam K, Shin I
. EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells. Arch Biochem Biophys. 2015; 575:69-76.
DOI: 10.1016/j.abb.2015.04.008.
View
17.
Atanassova M, Dimitrov G
. Synthesis and spectral characterization of novel compounds derived from 1,10-phenanthroline, lead(II) and tetrabutylammonium tetrafluoroborate. Spectrochim Acta A Mol Biomol Spectrosc. 2003; 59(7):1655-62.
DOI: 10.1016/s1386-1425(02)00397-9.
View
18.
Shrivastava N, Naim M, Alam M, Nawaz F, Ahmed S, Alam O
. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship. Arch Pharm (Weinheim). 2017; 350(6).
DOI: 10.1002/ardp.201700040.
View
19.
Chappell W, Lehmann B, Terrian D, Abrams S, Steelman L, McCubrey J
. p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3. Cell Cycle. 2012; 11(24):4579-88.
PMC: 3562303.
DOI: 10.4161/cc.22852.
View
20.
Loganathan R, Ramakrishnan S, Suresh E, Riyasdeen A, Akbarsha M, Palaniandavar M
. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity. Inorg Chem. 2012; 51(10):5512-32.
DOI: 10.1021/ic2017177.
View